News releases

Jul 1, 2011 "RepRegen CEO stepping down"

Jun 20, 2011 "Dr Stephan Rietiker resigns as Chairman of RepRegen"

Mar 2, 2011 "RepRegen receives visit from His Royal Highness, Prince Andrew, Duke of York...”

Feb 1, 2011 "RepRegen seeks US FDA 510(k) clearance for StronBone™...”
Click here for the German version.

Jan 5, 2011 "RepRegen to present at “OneMedForum 2011” ..."

Nov 4, 2010 "RepRegen raises £1.03m in additional capital..."
Click here for the German version.

Sept 30, 2010 "RepRegen discloses 6 month in vivo data confirming bone-regeneration properties of StronBone..."
Click here for the German version.

July 6, 2010 "RepRegen receives CE marking approval for StronBone..."

June 21, 2010 "RepRegen reports data from an in vivo study of StronBone..."

May 13, 2010 "RepRegen CEO Ian Brown to speak at INSEAD Leadership Summit...

March 8, 2010 "RepRegen reports potential advance in the repair and regeneration of hard tissue, such as bone..."

Archive Press Releases

The Company's focus and strategy has not changed since, as BioCeramic Therapeutics, it became a spin-out of Imperial College London 2006. The Company's name — RepRegen — reflects the features and benefits of its technology platforms, which are designed to repair and regenerate tissue in vivo. The name became effective in March 2010. Below are the Company's news releases when it was known as BioCeramic Therapeutics...

Jan 11, 2010 BioCeramic Therapeutics appoints New CEO...

Dec 10, 2009 BioCeramic Therapeutics wins ACES award...

Oct 20, 2009 BioCeramic Therapeutics receives new investment...

Oct 19, 2009 BioCeramic Therapeutics elects New Chairman...